Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

13 Canadian Crypto ETFs (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Rare Earths Stocks: 9 Biggest Companies in 2024

Uranium Stocks: 5 Biggest Companies in 2024

Top 4 Largest Lithium Reserves by Country (Updated 2024)

Can You Invest in Elon Musk’s Neuralink? (Updated 2024)

Trending Press Releases

Radiopharm achieves Nasdaq listing of ADS

HyProMag USA Feasibility Study Demonstrates Robust Economics and the Opportunity to Develop a Major New, Domestic Source of Recycled Rare Earths Magnets for the United States

New Murchison Gold Provides a Mineral Resource Update for the Crown Prince Deposit

First Helium Confirms Plans for Sequential Drilling of Two Oil Targets - Proven Undeveloped Oil Location and Large Leduc Anomaly

Antimony Project Acquired in Australia's Premier Province

Trillion Energy Successfully Re-completes Wells in VS Program

More Press Releases
Trending Companies

First Helium

HELI:CA

Soma Gold Corp.

SOMA:CA

Purpose Bitcoin ETF

BTCC:CA

Black Swan Graphene

SWAN:CC
More Companies
Trending Reports

2024 Gold Outlook Report

2024 Uranium Outlook

2024 Lithium Market Outlook

2024 Graphite Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Fusion Pharmaceuticals Inc.

NASDAQ:FUSN
Press Releases

Fusion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing alpha therapeutics for curing cancer. It develops Targeted Alpha Therapies (TAT) together with its proprietary Fast-Clear linker technology. The firm's lead product candidate comprises FPI-1434, a monotherapy for the treatment of a variety of cancers; FPI-1966, for the treatment of head and neck and bladder cancers; and FPI-2059 among others.

Interactive Chart

×